Literature DB >> 26680457

Reply.

M N Rozenfeld1, S A Ansari1, P Mohan2, A Shaibani1, E J Russell1, M C Hurley1.   

Abstract

Year:  2015        PMID： 26680457      PMCID： PMC7959931          DOI： 10.3174/ajnr.A4657

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  7 in total

Review 1.  Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen.

Authors:  A B Chapman; A M Johnson; P A Gabow
Journal:  Am J Kidney Dis       Date:  1993-10       Impact factor: 8.860

Review 2.  Should patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms?

Authors:  M N Rozenfeld; S A Ansari; A Shaibani; E J Russell; P Mohan; M C Hurley
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-04       Impact factor: 3.825

Review 3.  Cerebral aneurysms and polycystic kidney disease: a critical review.

Authors:  A M Lozano; R Leblanc
Journal:  Can J Neurol Sci       Date:  1992-05       Impact factor: 2.104

4.  Risk factors for the development and rupture of intracranial berry aneurysms.

Authors:  S M de la Monte; G W Moore; M A Monk; G M Hutchins
Journal:  Am J Med       Date:  1985-06       Impact factor: 4.965

Review 5.  Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies.

Authors:  Jacoba P Greving; Marieke J H Wermer; Robert D Brown; Akio Morita; Seppo Juvela; Masahiro Yonekura; Toshihiro Ishibashi; James C Torner; Takeo Nakayama; Gabriël J E Rinkel; Ale Algra
Journal:  Lancet Neurol       Date:  2013-11-27       Impact factor: 44.182

6.  Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease.

Authors:  W I Schievink; V E Torres; D G Piepgras; D O Wiebers
Journal:  J Am Soc Nephrol       Date:  1992-07       Impact factor: 10.121

7.  The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus.

Authors:  Nima Etminan; Robert D Brown; Kerim Beseoglu; Seppo Juvela; Jean Raymond; Akio Morita; James C Torner; Colin P Derdeyn; Andreas Raabe; J Mocco; Miikka Korja; Amr Abdulazim; Sepideh Amin-Hanjani; Rustam Al-Shahi Salman; Daniel L Barrow; Joshua Bederson; Alain Bonafe; Aaron S Dumont; David J Fiorella; Andreas Gruber; Graeme J Hankey; David M Hasan; Brian L Hoh; Pascal Jabbour; Hidetoshi Kasuya; Michael E Kelly; Peter J Kirkpatrick; Neville Knuckey; Timo Koivisto; Timo Krings; Michael T Lawton; Thomas R Marotta; Stephan A Mayer; Edward Mee; Vitor Mendes Pereira; Andrew Molyneux; Michael K Morgan; Kentaro Mori; Yuichi Murayama; Shinji Nagahiro; Naoki Nakayama; Mika Niemelä; Christopher S Ogilvy; Laurent Pierot; Alejandro A Rabinstein; Yvo B W E M Roos; Jaakko Rinne; Robert H Rosenwasser; Antti Ronkainen; Karl Schaller; Volker Seifert; Robert A Solomon; Julian Spears; Hans-Jakob Steiger; Mervyn D I Vergouwen; Isabel Wanke; Marieke J H Wermer; George K C Wong; John H Wong; Gregory J Zipfel; E Sander Connolly; Helmuth Steinmetz; Giuseppe Lanzino; Alberto Pasqualin; Daniel Rüfenacht; Peter Vajkoczy; Cameron McDougall; Daniel Hänggi; Peter LeRoux; Gabriel J E Rinkel; R Loch Macdonald
Journal:  Neurology       Date:  2015-08-14       Impact factor: 9.910
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.